Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy

Shahrzad Tehranian, Khaled Shawwa, Kianoush B Kashani, Shahrzad Tehranian, Khaled Shawwa, Kianoush B Kashani

Abstract

Background: Fluid overload, a critical consequence of acute kidney injury (AKI), is associated with worse outcomes. The optimal fluid removal rate per day during continuous renal replacement therapy (CRRT) is unknown. The purpose of this study is to evaluate the impact of the ultrafiltration rate on mortality in critically ill patients with AKI receiving CRRT.

Methods: This was a retrospective cohort study where we reviewed 1398 patients with AKI who received CRRT between December 2006 and November 2015 at the Mayo Clinic, Rochester, MN, USA. The net ultrafiltration rate (UFNET) was categorized into low- and high-intensity groups (<35 and ≥35 mL/kg/day, respectively). The impact of different UFNET intensities on 30-day mortality was assessed using logistic regression after adjusting for age, sex, body mass index, fluid balance from intensive care unit (ICU) admission to CRRT initiation, Acute Physiologic Assessment and Chronic Health Evaluation III and sequential organ failure assessment scores, baseline serum creatinine, ICU day at CRRT initiation, Charlson comorbidity index, CRRT duration and need of mechanical ventilation.

Results: The mean ± SD age was 62 ± 15 years, and 827 (59%) were male. There were 696 patients (49.7%) in the low- and 702 (50.2%) in the high-intensity group. Thirty-day mortality was 755 (54%). There were 420 (60%) deaths in the low-, and 335 (48%) in the high-intensity group (P < 0.001). UFNET ≥35 mL/kg/day remained independently associated with lower 30-day mortality (adjusted odds ratio = 0.47, 95% confidence interval 0.37-0.59; P < 0.001) compared with <35 mL/kg/day.

Conclusions: More intensive fluid removal, UFNET ≥35 mL/kg/day, among AKI patients receiving CRRT is associated with lower mortality. Future prospective studies are required to confirm this finding.

Keywords: acute kidney injury; dose–response relationship; fluid overload; mortality; net ultrafiltration; renal replacement therapy.

© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.

Figures

FIGURE 1
FIGURE 1
Patients flowchart.

References

    1. Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 2013; 84: 457–467
    1. Ostermann ME, Taube D, Morgan CJ et al.. Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Med 2000; 26: 565–571
    1. Mc Causland FR, Brunelli SM, Waikar SS. Dialysate sodium, serum sodium and mortality in maintenance hemodialysis. Nephrol Dial Transplant 2012; 27: 1613–1618
    1. Schoenfelder T, Chen X, Bless HH. Effects of continuous and intermittent renal replacement therapies among adult patients with acute kidney injury. GMS Health Technol Assess 2017; 13: doi: 10.3205/hta000127
    1. Kellum JA, Lameire N, Group K. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17: 204.
    1. Iwagami M, Yasunaga H, Noiri E et al.. Current state of continuous renal replacement therapy for acute kidney injury in Japanese intensive care units in 2011: analysis of a national administrative database. Nephrol Dial Transplant 2015; 30: 988–995
    1. Choi SJ, Ha EJ, Jhang WK et al.. Factors associated with mortality in continuous renal replacement therapy for pediatric patients with acute kidney injury. Pediatr Crit Care Med 2017; 18: e56–e61
    1. Dos Santos TOC, Oliveira MAS, Monte JCM et al.. Outcomes from a cohort of patients with acute kidney injury subjected to continuous venovenous hemodiafiltration: the role of negative fluid balance. PLoS One 2017; 12: e0175897.
    1. Kim IY, Kim JH, Lee DW et al.. Fluid overload and survival in critically ill patients with acute kidney injury receiving continuous renal replacement therapy. PLoS One 2017; 12: e0172137.
    1. Sharma S, Waikar SS. Intradialytic hypotension in acute kidney injury requiring renal replacement therapy. Semin Dial 2017; 30: 553–558
    1. Woodward CW, Lambert J, Ortiz-Soriano V et al.. Fluid overload associates with major adverse kidney events in critically ill patients with acute kidney injury requiring continuous renal replacement therapy. Crit Care Med 2019; 47: e753–e760
    1. Bouchard J, Soroko SB, Chertow GM et al.. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009; 76: 422–427
    1. Dalfino L, Tullo L, Donadio I et al.. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med 2008; 34: 707–713
    1. Payen D, de Pont AC, Sakr Y et al.. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12: R74.
    1. Jaeger JQ, Mehta RL. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999; 10: 392–403
    1. Kashani K, Mehta RL. We restrict CRRT to only the most hemodynamically unstable patients. Semin Dial 2016; 29: 268–271
    1. Selby NM, Burton JO, Chesterton LJ et al.. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 2006; 1: 1216–1225
    1. Kramer H, Yee J, Weiner DE et al.. Ultrafiltration rate thresholds in maintenance hemodialysis: an NKF-KDOQI controversies report. Am J Kidney Dis 2016; 68: 522–532
    1. Murugan R, Balakumar V, Kerti SJ et al.. Net ultrafiltration intensity and mortality in critically ill patients with fluid overload. Crit Care 2018; 22: 223.
    1. Palevsky PM, Molitoris BA, Okusa MD et al.. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol 2012; 7: 844–850
    1. Akhoundi A, Singh B, Vela M et al.. Incidence of adverse events during continuous renal replacement therapy. Blood Purif 2015; 39: 333–339
    1. RENAL Replacement Therapy Study InvestigatorsBellomo R, Cass A, Cole L et al.. An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial. Crit Care Med 2012; 40: 1753–1760
    1. Vaara ST, Korhonen AM, Kaukonen KM et al.. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care 2012; 16: R197.
    1. Saran R, Bragg-Gresham JL, Levin NW et al.. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69: 1222–1228
    1. Assimon MM, Wenger JB, Wang L et al.. Ultrafiltration rate and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2016; 68: 911–922
    1. Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011; 79: 250–257
    1. Kim JK, Song YR, Park G et al.. Impact of rapid ultrafiltration rate on changes in the echocardiographic left atrial volume index in patients undergoing haemodialysis: a longitudinal observational study. BMJ Open 2017; 7: e013990
    1. Ronco C, Bellomo R, Homel P et al.. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26–30
    1. Saudan P, Niederberger M, De Seigneux S et al.. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70: 1312–1317
    1. Murugan R, Kerti SJ, Chang CH et al.. Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs. augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open 2019; 2: e195418.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever